COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03432884
Brief Title: A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects

First Submitted : January 19, 2018
First Submitted that Met QC Criteria : February 13, 2018
First Posted : February 14, 2018

Last Update Submitted that Met QC Criteria : April 22, 2020
Last Update Posted : April 24, 2020